hepat
c
viru
hcv
form
genu
hepaciviru
within
flavivirida
famili
hcv
positivestrand
rna
viru
encod
singl
polyprotein
precursor
gener
rna
translat
rough
endoplasm
reticulum
er
polyprotein
proteolyt
process
matur
protein
preferenti
obligatori
order
figur
separ
structur
protein
ie
core
envelop
glycoprotein
nonstructur
protein
save
essenti
viral
rna
replic
importantli
polyprotein
process
regul
event
give
rise
cleavag
intermedi
best
illustr
fact
identif
isol
product
evid
predict
due
ineffici
cleavag
precursor
signal
peptidas
er
figur
initi
attempt
ascrib
distinct
function
viral
life
cycl
complic
lack
adequ
cell
cultur
model
propag
hcv
cultur
cell
limit
avail
reliabl
antibodi
recogn
initi
develop
selfrepl
subgenom
replicon
base
hcv
replicas
factor
ie
ntr
demonstr
structur
protein
dispens
viral
rna
replic
howev
sinc
replicon
recapitul
intracellular
step
hcv
replic
cycl
possibl
role
viru
product
could
address
time
specul
might
membran
permeabil
protein
involv
viru
productionreleas
assumpt
base
silico
predict
membran
topolog
similar
protein
relat
pestivirus
protein
alphavirus
latter
wellstudi
member
famili
viroporin
strong
support
ion
channelporelik
activ
hcv
obtain
vitro
studi
demonstr
partial
select
cation
also
small
molecul
howev
studi
role
hcv
viru
product
becam
possibl
molecular
clone
genotyp
gt
isol
design
japanes
patient
suffer
fulmin
hepat
isol
effici
replic
human
hepatoma
cell
line
produc
infecti
viru
particl
use
demonstr
essenti
particl
assembl
releas
find
consist
earlier
studi
demonstr
essenti
product
hcv
propag
vivo
use
seri
intra
intergenotyp
chimer
hcv
genom
observ
extend
mani
hcv
gt
interestingli
use
hcvlike
particl
inhibitor
contribut
enhanc
viru
entri
propos
howev
difficulti
detect
infecti
viru
particl
well
observ
delet
affect
hcv
specif
infect
rais
controversi
viroporin
form
grow
famili
viral
protein
identifi
rna
dna
virus
protein
abl
oligomer
form
hydrophil
pores
channel
host
cell
membran
viroporin
share
common
featur
small
size
hydrophob
presenc
least
one
amphiphat
transmembran
domain
cytopathogen
main
consequ
viroporin
express
infect
disrupt
ionic
gradient
across
target
membran
therebi
alter
physiolog
cell
function
hand
viroporin
action
result
establish
favor
environ
differ
step
viral
life
cycl
often
exclus
assembl
virion
releas
infect
cell
instanc
case
vpu
alphaviru
influenza
viru
sarscov
sever
acut
respiratori
syndrom
coronaviru
e
hcv
delet
viroporin
code
sequenc
reduc
product
infecti
viru
particl
pathogen
follow
section
discuss
major
find
relat
structur
function
hcv
viroporin
well
possibl
use
antivir
therapi
base
protein
structur
membran
topolog
two
major
class
ii
two
subclass
b
viroporin
defin
third
class
includ
viroporin
three
hydrophob
domain
also
propos
respect
hcv
class
iia
viroporin
length
amino
acid
residu
form
two
transmembran
span
region
separ
basic
cytoplasm
loop
n
ctermini
face
er
lumen
figur
howev
altern
topolog
cterminu
expos
cytoplasm
propos
deduc
express
precursor
protein
tendenc
form
homooligom
assembl
ion
channellik
structur
vitro
report
sever
laboratori
result
base
use
recombin
synthet
peptid
insert
artifici
lipid
bilay
overexpress
xenopu
oocyt
electrophysiolog
record
techniqu
includ
patchclamp
twoelectrod
voltag
clamp
support
electron
microscopi
em
biochem
data
comput
model
techniqu
silico
analysi
hcv
sequenc
predict
hairpinlik
structur
monom
ntermin
transmembran
domain
tmd
line
lumen
pore
figur
initi
studi
use
transmiss
em
tem
computerbas
imag
analysi
reveal
fusion
protein
form
mix
hexamer
heptamer
complex
liposom
result
obtain
equilibrium
sediment
experi
consist
format
differ
oligomer
state
compris
subunit
heterogen
depend
strongli
deterg
thu
biolog
membran
might
exist
mixtur
oligom
variabl
size
subsequ
tem
studi
combin
singl
particl
reconstruct
chemic
synthes
fulllength
solubil
short
chain
dhpc
deterg
micel
ph
provid
first
structur
hexamer
channel
resolut
found
channel
exist
flowershap
complex
petal
emerg
conic
base
gener
first
em
densiti
map
studi
allow
model
simul
monom
hexamer
volum
high
fit
valu
well
predict
interact
lower
part
channel
moreov
topolog
complex
indic
n
ctermini
monom
expos
toward
tip
petal
could
confirm
immunogold
label
specif
antibodi
accordingli
open
part
channel
suggest
protrud
er
lumen
figur
embas
model
subsequ
adopt
use
templat
reconstruct
channel
gt
nmrsolv
monomer
structur
current
four
nmrbase
structur
hcv
monom
report
figur
first
monserret
cowork
obtain
structur
second
tmd
dissolv
trifluoroethanolwat
mixtur
present
model
monom
base
structur
data
experi
membran
mimet
nmrstructur
fulllength
obtain
methanol
foster
colleagu
structur
cook
cowork
reveal
monom
ph
reconstitut
micel
form
dhpc
contain
short
acyl
chain
interestingli
nmrbase
structur
report
ouyang
cowork
determin
micel
dpc
ie
dodecylphosphocholin
contain
longer
acyl
chain
assum
hexamer
oligomer
size
basi
parallel
neg
stain
em
experi
clear
similar
found
differ
subtyp
hcv
notabl
discrep
appar
structur
figur
b
wherea
monom
exhibit
classic
hairpinlik
conform
monom
display
extend
complex
distribut
element
tilt
unusu
way
figur
b
hairpin
model
three
four
helic
segment
distinguish
variabl
posit
depend
report
structur
figur
structur
group
opella
penin
ntermin
connect
first
tm
helix
flexibl
turn
propos
interact
head
group
lipid
bilay
deduc
molecular
dynam
simul
helic
region
membran
interfac
might
adopt
almost
perpendicular
angl
subsequ
transmembran
helix
structur
griffin
group
first
two
helic
segment
isol
appear
singl
transmembran
helix
figur
addit
structur
cytosol
loop
separ
first
transmembran
region
second
one
latter
exhibit
certain
variabl
includ
one
two
helic
element
differ
posit
ctermin
part
propos
either
structur
includ
short
flexibl
helix
figur
c
overal
appear
flexibl
protein
support
structur
differ
observ
variou
group
import
note
role
lipid
organ
solvent
defin
composit
thick
membran
thu
influenc
final
conform
despit
differ
number
distribut
secondari
structur
element
within
monom
surpris
channel
subunit
share
hairpin
conform
antiparallel
tm
region
slightli
tilt
lipid
bilay
figur
c
regard
unclear
monom
present
unusu
distinct
conform
figur
right
panel
nevertheless
structur
repres
first
exampl
conform
subunit
extract
nmrbase
hexamer
complex
reveal
three
alpha
helic
region
tilt
sharp
angl
adopt
curv
staplelik
conform
first
third
helix
separ
second
helix
kink
gli
figur
interestingli
residu
locat
two
highli
conserv
basic
amino
acid
residu
crucial
viru
particl
infect
vivo
import
ion
channel
activ
differ
posit
helic
element
protein
differ
gt
extend
arrang
monom
within
assembl
channel
reveal
unexpect
featur
compar
model
lack
unstructur
loop
connect
two
transmembran
region
ctermin
region
embed
lipid
bilay
figur
studi
ouyang
cowork
also
provid
import
detail
overal
architectur
pore
interestingli
oligom
embed
membran
exhibit
funnellik
shape
resembl
flowerlik
shape
model
fit
within
em
map
high
accuraci
correl
coeffici
even
though
deterg
concentr
use
reconstitut
nmr
em
analysi
hexamer
architectur
stabil
multipl
interact
amongst
monom
way
third
ctermin
helix
one
monom
interact
second
helix
neighbor
monom
first
ntermin
helix
consecut
one
figur
complex
rearrang
subunit
might
evok
process
cofold
least
vitro
condit
use
protein
renatur
presenc
dpc
howev
remain
enigmat
whether
structur
could
obtain
physiolog
context
sinc
cofold
explain
current
understand
protein
fold
cellulo
fact
intramonom
interact
suggest
previou
nmr
embas
studi
absent
structur
novel
noteworthi
nmr
structur
narrow
part
hydrophil
channel
form
tight
associ
helic
ntermini
follow
wider
region
form
helic
accord
studi
structur
protrus
petal
mainli
correspond
helic
surround
packag
central
caviti
second
half
helic
interconnect
region
repres
petal
tip
therefor
flowerlik
architectur
present
topolog
distinct
previous
describ
figur
exist
altern
structur
monom
could
explain
least
part
genet
divers
amino
acid
sequenc
use
experiment
condit
employ
studi
howev
possibl
might
account
appar
structur
discrep
link
gt
character
structur
ideal
cell
infect
hcv
differ
gt
help
corrobor
new
find
model
hexamer
heptamer
channel
obtain
molecular
dynam
use
either
predict
nmrbase
structur
correspond
monom
insert
lipid
bilay
studi
bundl
display
lumin
orient
first
tmd
ctermin
tm
region
face
membran
hydrophob
phase
surround
channel
figur
strikingli
silicobas
studi
secondari
structur
monom
predict
hairpinlik
fold
reminisc
nmr
structur
basi
report
curv
staplelik
conform
monom
assembl
channel
could
predict
priori
similarli
structur
complet
oligomer
complex
report
ouyang
cowork
expect
light
computerpredict
conform
monom
thu
one
expect
conform
chang
induc
monomer
hairpin
upon
oligomer
case
monom
might
exert
differ
function
compar
oligom
consist
differ
report
function
hcv
life
cycl
either
depend
independ
ion
channel
activ
see
section
howev
analys
hexam
reveal
featur
argu
exist
structur
physiolog
membran
environ
one
presenc
posit
charg
side
chain
correspond
arginin
residu
expos
hydrophob
membran
phase
although
might
due
micel
composit
shape
difficult
reconcil
cellular
membran
environ
anoth
exampl
exist
hexam
sever
hydrophil
caviti
embed
hydrophob
core
lipid
membran
thu
view
flexibl
structur
interact
lipid
obtain
physiolog
relev
structur
requir
studi
true
membranelik
environ
mimick
composit
thick
er
although
well
establish
differ
hcv
gt
form
homooligom
heterogen
size
vitro
exist
mixtur
speci
infect
hepatocyt
remain
determin
addit
initi
studi
membran
topolog
cell
base
express
isol
precursor
therefor
valid
infectionbas
system
use
fulllength
hcv
genom
encod
fulli
function
tag
version
differ
gt
requir
biochem
character
complex
form
infect
cell
allow
determin
physiolog
relev
structuresconform
propos
monom
far
predominantli
deduc
nmrbase
approach
vitro
due
small
size
high
hydrophob
tendenc
form
oligom
cellular
membran
viroporin
ideal
candid
explain
chang
membran
permeabl
occur
cell
infect
differ
virus
membran
alter
describ
studi
assess
entri
releas
small
compound
cultur
cell
artifici
liposom
instanc
antibiot
hygromycin
b
hb
molecular
weight
dalton
extens
use
probe
evalu
increas
membran
permeabl
upon
individu
express
variou
viroporin
although
indirect
assay
ie
hb
select
enter
cell
enhanc
membran
permeabl
inhibit
protein
synthesi
presenc
viroporin
cell
surfac
common
hallmark
virusinfect
cell
approach
invalu
studi
viroporin
function
mani
famili
member
nevertheless
whether
entri
hb
cell
occur
directli
via
viroporinassembl
pore
cell
surfac
indirectli
upregul
endocytosi
remain
explor
biophys
assay
monitor
releas
dye
defin
size
preload
liposom
initi
use
establish
porelik
properti
protein
well
predict
size
inner
channel
similar
liposomebas
approach
use
small
fluoresc
probe
carboxyfluorescein
kda
phsensor
hpt
acid
employ
corrobor
format
pore
hcv
differ
gt
system
also
adapt
high
throughput
screen
aim
find
hcv
inhibitor
taken
togeth
nonselect
pore
properti
evidenc
vitro
assay
howev
studi
requir
corrobor
assum
direct
passag
larg
molecul
cultur
cell
via
protein
influenza
viru
kcv
protein
chlorella
viru
highli
select
proton
potassium
respect
viroporin
show
low
ion
select
appear
case
also
hcv
minor
prefer
cation
vs
anion
shown
electrophysiolog
record
techniqu
artifici
bilay
xenopu
laevi
oocyt
recent
studi
provid
strong
evid
proton
conduct
differ
gt
ie
isol
intracellular
membran
vesicl
hcvinfect
cell
function
resembl
hcv
viroporin
influenza
viru
iav
common
acidactiv
proton
channel
activ
suggest
viroporin
might
share
similar
gate
mechan
proton
gate
mechan
extens
studi
involv
sequenc
motif
tm
region
two
key
amino
acid
project
center
pore
protonconduct
residu
identifi
proton
gate
base
nmr
data
obtain
monomer
potenti
equival
residu
line
lumen
channel
residu
correspond
conserv
amino
acid
residu
tyrtrp
present
absent
ser
found
figur
function
relev
residu
differ
gt
confirm
sever
mutagenesisbas
studi
moreov
role
gate
residu
suggest
liposomebas
assay
measur
enhanc
permeabil
capac
confer
alanin
substitut
use
molecular
dynam
simul
residu
togeth
observ
form
energet
barrier
water
permeat
consist
sequenc
structur
diverg
hexamer
structur
reveal
altern
gate
mechan
basi
hypothet
cation
select
two
constrict
point
would
regul
ion
flux
basic
ring
form
wider
ctermin
open
doubl
ring
includ
narrow
base
although
cation
channel
activ
proven
case
mutat
amino
acid
equival
posit
decreas
cation
channel
activ
whilst
structur
data
conclus
valid
propos
gate
system
still
support
function
influenc
residu
ion
channel
activ
addit
channel
structur
requir
elucid
whether
function
gate
residu
hcv
gt
distinct
gt
subtyp
moreov
taken
account
lipid
environ
influenc
structur
thu
electrophysiolog
properti
fact
recent
studi
suggest
two
differ
conform
presum
influenc
lipid
environ
like
account
proton
select
influenc
content
structur
permeabl
larg
molecul
affect
content
least
liposomebas
assay
even
though
high
content
thought
artifact
studi
corrobor
plastic
structur
suggest
altern
conform
might
exist
therebi
explain
multipl
function
hcv
infect
cell
although
great
advanc
made
hcv
field
last
year
still
far
away
comprehens
understand
relationship
viroporin
mainli
due
use
differ
hcv
gt
subtyp
presenc
tag
use
protein
purif
detect
well
experiment
condit
technolog
appli
differ
laboratori
thu
futur
research
field
requir
multidisciplinari
gt
crosscompar
analys
discern
report
biophys
function
vitro
channel
properti
act
hcvinfect
cell
propos
act
low
phactiv
channel
hcvinfect
cell
similar
iav
viroporin
equilibr
proton
gradient
across
membran
acid
compart
dissip
proton
lumen
acid
compart
cytoplasm
result
alcalin
organel
requir
final
step
viru
assembl
subsequ
egress
virion
mutant
conserv
dibas
motif
cytosol
loop
affect
unabl
regul
proton
gradient
result
impair
porelik
ion
channel
activ
artifici
lipid
bilay
moreov
peptid
contain
mutat
show
reduc
membran
bind
affin
although
mutat
associ
delay
cleavag
precursor
eg
degrad
eg
might
account
impair
viru
product
recent
studi
confirm
import
basic
residu
ion
channel
activ
point
direct
link
proton
channel
activ
product
hcv
infecti
particl
consist
observ
partial
restor
viru
product
iav
viroporin
rescu
mutant
use
transcomplement
assay
likewis
partial
rescu
infecti
viru
product
achiev
pharmacolog
inhibit
endosom
vesicl
acidif
use
bafilomycin
inhibitor
vacuolartyp
protonatpas
accordingli
phdepend
matur
process
suggest
preced
secret
infecti
virion
assumpt
reinforc
fact
infecti
intracellular
particl
highli
sensit
treatment
acid
ph
wherea
secret
virion
acidresist
moreov
acid
stabil
secret
viru
particl
seem
influenc
gtdepend
manner
consid
data
ion
channel
might
regard
modul
phmediat
matur
process
hcv
particl
howev
matur
process
regul
confer
acid
resist
signatur
secret
particl
exit
known
prevent
prematur
conform
chang
hcv
envelop
glycoprotein
reminisc
function
iav
propos
other
attract
possibl
deserv
investig
recent
shown
hcv
envelop
glycoprotein
interact
apolipoprotein
integr
compon
infecti
virion
sinc
also
interact
envelop
glycoprotein
tempt
specul
might
also
influenc
apolipoprotein
incorpor
hcv
particl
particl
matur
thu
contribut
viru
product
infect
biochem
studi
confirm
mainli
exclus
interact
assum
act
organ
virion
assembl
interact
requir
ion
channel
activ
instead
like
serv
recruit
envelop
glycoprotein
via
interact
turn
associ
site
hcv
assembl
way
regul
subcellular
local
core
protein
addit
associ
shown
dictat
reloc
core
ld
er
infect
cell
redistribut
like
requir
hcv
assembl
reflect
assembl
effici
correl
high
infect
titer
apart
interact
recent
studi
interact
network
hcv
protein
point
core
two
envelop
glycoprotein
new
direct
bind
partner
genet
data
suggest
associ
use
expressionbas
system
found
local
mainli
er
also
membran
close
mitochondria
plasma
membran
howev
studi
limit
lack
antibodi
therefor
tag
version
unclear
physiolog
function
use
recent
sever
group
gener
fulllength
hcv
genom
encod
doubl
hatag
chimer
protein
fulli
function
studi
reveal
predomin
local
er
perinuclear
region
moreov
found
coloc
glycoprotein
well
core
gener
assum
nucleocapsid
format
envelop
hcv
particl
coupl
reaction
thu
block
envelop
would
prevent
nucleocapsid
assembl
concomit
intracellular
accumul
core
protein
surfac
ld
envelop
glycoprotein
vicin
assembl
site
consist
assumpt
studi
dibas
motif
mutant
reveal
gtdepend
reduct
intracellular
infect
like
result
incomplet
incorpor
viral
rna
nucleocapsid
aberrantli
accumul
surfac
ld
demonstr
hcv
chimera
moreov
immatur
capsid
lack
er
membranederiv
viral
envelop
strikingli
noninfecti
nucleocapsidcontain
particl
densiti
compar
infecti
hcv
thu
like
possess
envelop
glycoprotein
isol
cell
infect
mutant
hcv
isol
appar
discrep
virus
differ
assembl
fit
could
explain
least
part
gtspecif
interact
structur
protein
overal
find
suggest
involv
consecut
step
assembl
hcv
particl
includ
earli
encapsid
viral
genom
reloc
rnacontain
core
complex
ld
er
eventu
acquisit
membran
envelop
fact
step
suffici
confer
infect
viral
particl
isol
argu
particl
matur
late
ratelimit
step
product
releas
infecti
hcv
virion
respect
would
two
function
first
particip
envelop
viru
particl
mediat
interact
envelop
glycoprotein
turn
via
associ
recruit
replicas
second
mediat
regul
intracellular
matur
step
hcv
particl
render
phresist
fulli
infecti
number
compound
report
exert
inhibitori
effect
hcv
channel
activ
compris
classic
inhibitor
iav
viroporin
adamantan
amantadin
rimantadin
iminosugar
deriv
eg
nnonyl
deoxynojirimycin
nndnj
hexamethylamilorid
hma
specif
compound
develop
glaxosmithklin
effect
ion
channelporelik
activ
vitro
assess
either
electrophysiolog
record
techniqu
use
reconstitut
artifici
lipid
bilay
liposomebas
assay
overal
compound
inhibit
depend
hcv
gt
subtyp
variou
effici
instanc
higher
theoret
bind
affin
rimantadin
kd
respect
compar
amantadin
kd
respect
reflect
lower
kd
valu
explain
increas
inhibitori
potenc
sever
compound
also
studi
infect
cell
found
reduc
viru
product
gtdepend
manner
inhibitori
phenotyp
character
reduc
secret
hcv
particl
without
impair
infect
intracellular
virion
compound
mechan
respons
reduct
viru
secret
poorli
understood
case
iminosugar
deriv
nndnj
inhibit
lead
alter
glycosyl
pattern
total
level
hcv
might
mechan
ad
direct
bind
inhibit
howev
recent
report
product
hcv
releas
link
inhibit
acidif
viruscontain
compart
mediat
process
block
adamantan
hma
consist
propos
role
ion
channel
earli
infect
step
hcv
gtdepend
block
viru
entri
describ
adamantan
nndnj
howev
observ
inact
mutant
affect
specif
infect
releas
hcv
particl
consist
mechan
inhibit
moreov
involv
ion
channel
activ
celltocel
transmiss
hcv
unlik
deduc
limit
inhibitori
effect
antagonist
mode
viru
spread
thu
primarili
consid
attract
target
block
viru
releas
take
advantag
structur
heptam
silicobas
screen
potenti
ligand
conduct
lead
identif
seri
compound
improv
inhibitori
effect
viru
chimera
compound
bind
peripher
alloster
site
predict
rimantadin
bind
pocket
consist
secret
rimantadineresist
viru
contain
phenylalanin
substitut
suppress
new
drug
addit
encourag
data
show
dose
compound
concentr
low
micro
molar
rang
suffici
suppress
product
chimer
virus
deriv
sever
gt
thu
far
resist
novel
inhibitor
report
clinic
develop
inhibitor
met
limit
success
consist
low
antivir
efficaci
amantadin
hcv
cell
cultur
system
clinic
benefit
amantadinebas
combin
therapi
found
comparison
standard
care
plu
ribavirin
thu
far
promis
effect
report
tripl
therapi
earli
reduct
viremia
effect
accompani
sustain
virolog
respons
perhap
effici
effect
inhibitor
report
amilorid
deriv
develop
biotron
target
addit
hcv
hiv
viroporin
vpu
pestiviru
bvdv
vitro
infect
cell
inhibitori
effect
hcv
channel
suggest
dock
assay
confirm
lipid
bilay
system
although
data
report
context
hcv
infect
dock
studi
reveal
amilorid
deriv
seem
bind
best
hexamer
exhibit
lowest
bind
energi
kcalmol
compar
inhibitor
amantadin
kcalmol
nndnj
kcalmol
one
earli
clinic
trial
phase
ibiia
treatment
hcv
patient
indic
signific
reduct
viral
load
twelv
week
treatment
combin
wwwbiotroncomau
biotron
current
phase
clinic
trial
progress
first
result
indic
activ
sever
hcv
gt
includ
difficulttotreat
wwwbiotroncomau
may
moreov
might
suitabl
treatment
hcvhiv
coinfect
patient
howev
light
high
potenc
avail
inhibitor
target
serinetyp
proteas
replicas
factor
rnadepend
rna
polymeras
clinic
nich
inhibitor
unclear
one
limit
select
antivir
therapi
drug
resist
unfortun
inhibitor
except
case
adamantan
mutat
confer
rimantadin
resist
found
patient
respond
tripl
therapi
case
iminosugar
deriv
disrupt
oligomer
thu
channel
activ
polymorph
present
hcv
gt
shown
mediat
nndnj
resist
stabil
channel
avail
effici
fulli
permiss
cell
cultur
model
hcv
knowledg
role
viral
life
cycl
increas
profoundli
becam
clear
protein
play
major
role
assembl
releas
infecti
hcv
particl
appear
mediat
two
complementari
function
first
associ
envelop
glycoprotein
particip
coordin
envelop
viru
particl
second
form
channel
appear
requir
intracellular
matur
step
virion
requir
secret
render
ph
resist
recent
resolut
homohexam
structur
mean
cryoem
nmr
reveal
unexpect
arrang
subunit
differ
typic
hairpin
conform
propos
novel
gate
mechan
notabl
achiev
import
question
still
remain
solv
instanc
basi
structur
divers
ion
channel
contribut
viru
releas
render
intracellular
hcv
particl
ph
resist
clinic
point
view
chronic
hepat
c
might
regard
solv
problem
studi
hcv
continu
provid
import
insight
intric
cell
interplay
respect
studi
hcv
help
unravel
viroporin
also
use
mani
virus
promot
product
infecti
progeni
particl
eventu
contribut
pathogen
